ScholarWorks@Korea University College of Medicine: Chung, Hye won

Detailed Information

Chung, Hye won (정혜원)

Guro Hospital (Department of Clinical Pharmacology and Toxicology, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

pharmacokinetics:12||pharmacodynamics:3||bioequivalence:2||clinical trial:2||metformin:2||clinical trials:2||drug interaction:2||Phase I:2||dabigatran:2||elderly:2||escitalopram:2||Drug interaction:1||Druginduced liver injury:1||Electronic medical record:1||Fatty acid:1||Flavonoid:1||GUDCA:1||Global metabolomics:1||Helicobacter pylori:1||Hepatoprotective effect:1||Hepatotoxicity:1||Humira:1||LCMS/MS:1||LC280126:1||MATE:1||Pharmacokinetics:1||QT interval:1||RCI001:1||STI571:1||Sodiumglucose transporter 2 inhibitors:1||TUDCA:1||UDCA:1||Ursodeoxycholic acid:1||alpha1 acid glycoprotein:1||antiTNF:1||anticoagulation:1||bioavailability:1||bismuth:1||cholic acid:1||curcumin:1||dabigatran acylglucuronide:1||dapagliflozin:1||diabetes:1||drug safety:1||drug transporter:1||fixeddose combination products:1||genetic polymorphism:1||geriatrics:1||glivec:1||healthy volunteer:1||imatinib (gleevec):1||immunogenicity:1||inflammation:1||interaction:1||linagliptin:1||moxifloxacin:1||ocular pharmacokinetics:1||pharmacodynamic:1||pharmacogenetics:1||pharmacokinetic:1||quadruple therapy:1||quetiapine:1||safety:1||simvastatin:1||therapeutic drug monitoring:1||thrombin generation:1||tocilizumab:1||tolerability:1||vonoprazan:1||8oxodG:1||voriconazole:1||ABCG2 (BCRP):1||Adalimumab:1||Amino acid:1||Biosimilar:1||CTP47:1||CYP2C19:1||Dabigatran:1||Dabigatran acylglucuronide:1||Dabigatran etexilate:1||Dipeptidylpeptidase IV inhibitors:1||

STATISTICS: Total View :12,799,769; Today View :8,621

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE